Grail Blood Test Nears FDA Approval Amid Insurance Concerns
An FDA advisory panel has recommended Grail's Galleri blood test for early cancer detection, signaling a significant step toward potential approval. However, uncertainty remains regarding insurance coverage for the test, which could impact its widespread adoption.